Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GPCR
#725
Structure Therapeutics Inc. American Depositary Shares
62.980
0
-0.54%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-0.54%
Monthly Change
-29.15%
6 month change
+135.53%
Year Change
+135.53%
Previous Close
63.325
0
Open
62.950
0
Bid
Ask
Low
62.950
0
High
62.980
0
Volume
46
Markets
US Stock Market
Healthcare
GPCR
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2023
2024
2025
Total assets
482.02 M
903.33 M
1.58 B
Total liabilities
29.05 M
38.49 M
67.54 M
Total equity
452.97 M
864.84 M
1.52 B
Total liabilities & shareholders' equities
482.02 M
903.33 M
1.58 B
Total debt
—
—
—
Net debt
—
—
—
News
Structure Therapeutics shares could rise on obesity drug data, Cantor says
Citizens cuts Structure Therapeutics stock price target on pipeline expansion
Lilly's GLP-1 Blockbusters Drive 2025 Revenue Surge: What's Ahead?
Lilly vs. Novo Nordisk: Obesity Drug Giants' Face-Off in 2026
Novo Nordisk Dives As Next-Gen Obesity Drug Lags Eli Lilly's Kingpin
Structure Therapeutics: The Dark Horse Has Taken The Lead - But Is It Enough? (GPCR)
Can LLY's Next-Gen Obesity Pipeline Sustain Growth Amid Competition?
How to Play Eli Lilly Stock Following a Robust Q4 Earnings Report
Eli Lilly's 2025 Surge Sets the Stage for Another Big Year in 2026
Hims & Hers Health Stops Offering Knockoff Wegovy Pill Amid FDA Crackdown
Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales Outlook
Obesity stocks slump on Novo’s underwhelming 2026 sales forecast